You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Rui Zheng1, Zhuo Chen1, Xiao-Ying Zhong1
1Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Age, gender, allergies, and combining Xuebijing Injection (XBJ) with other β-lactam antimicrobials are key risk factors for severe adverse events (AEs). Careful clinical consideration of these factors, especially XBJ-β-lactam combinations, is crucial for patient safety.
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: